19.04
+0.19
(1.01%)
Jun 18 - Close
NASDAQ
real-time data -
Disclaimer
Currency in USD
| Range | 18.77 - 19.05 |
| 52 week | 18.00 - 25.89 |
| Open | 18.78 |
| Vol / Avg. | 3.30M/5.62M |
| Mkt cap | 6.05B |
| P/E | 41.44 |
| Div/yield | - |
| EPS | 0.46 |
| Shares | 317.75M |
| Beta | 1.48 |
| Inst. own | 93% |
Events
Aug 5, 2013
Q3 2013 Nuance Communications, Inc. Earnings Release
May 30, 2013
Nuance Conference Call to Discuss Its Agreement to Acquire Tweddle Connect -
May 7, 2013
Q2 2013 Nuance Communications, Inc. Earnings Release
Apr 30, 2013
Q2 2013 Nuance Communications, Inc. Conferece Call
|
More events from DailyFinance »
|
Key stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | -5.73% | 12.54% |
| Operating margin | 2.75% | 7.64% |
| EBITD margin | - | 23.03% |
| Return on average assets | -1.70% | 4.19% |
| Return on average equity | -3.74% | 7.86% |
| Employees | 12,000 | - |
| Carbon Disclosure Rating | - | - |
Address
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
Nuance Communications, Inc. is a provider of voice and language solutions for businesses and consumers globally. The Company's solutions are used in healthcare, mobile, consumer, enterprise customer service, and imaging markets. The Company offers accuracy, natural language understanding capability, domain knowledge and implementation capabilities. The Company's solutions are based on the Company's voice and language platform and are used by businesses for tasks and services, such as requesting information from a phone-based self-service solution, dictating medical records, searching the mobile Web by voice, entering a destination into a navigation system, or working with portable document format (PDF) documents. On June 1, 2012, the Company acquired Vlingo Corporation. In December 2012, the Company acquired Ditech Networks, Inc. Effective April 1, 2013, Carl Icahn acquired a 9.27% stake in the Company.
Officers and directors
| Paul A. Ricci | Chairman of the Board, Chief Executive Officer | |
| Thomas L. Beaudoin | Chief Financial Officer, Executive Vice President | |
| Steven G. Chambers | President - Worldwide Sales and Marketing | |
| Janet M. Dillione | Executive Vice President and General Manager - Healthcare Business | |
| William Kenneth Nelson | Executive Vice President - Worldwide Sales | |
| Adam Bruce Bowden | Senior Vice President - Corporate Strategy | |
| Todd M. Duchene | Secretary | |
| Robert J. Frankenberg | Lead Independent Director | |
| Patrick T. Hackett | Independent Director | |
| William H. Janeway Ph.D. | Independent Director |